Enrico Marco Heffler

Formazione

2014: Dottorato in Medicina e Terapia Sperimentale (indirizzo: Farmacologia Clinica e Sperimentale)
2008: Specializzazione in Allergologia e Immunologia Clinica, Università degli Studi di Torino
2003: Laurea in Medicina e Chirurgia, Università degli Studi di Torino

Incarichi Accademici

2020 – presente: Professore Associato in Medicina Interna, Humanitas University, Milano
2017 – 2020: Ricercatore Universitario in Malattie dell’Apparato Respiratorio, Humanitas University, Milano
2015 – 2017: Ricercatore Universitario in Malattie dell’Apparato Respiratorio, Università degli Studi di Catania

Affiliazioni

2021 – presente: Steering Committee Member, Severe Heterogeneous Asthma Research collaboration, Patient-centred (SHARP), European Respiratory Society (ERS)
2021 – presente: Steering Committee Member and Principal Investigator, Registro Italiano dell’Allergen-ImmunoTherapy (RIAIT)
2021 – presente: Steering Committee Member and Principal Investigator, Rhinosinusitis Italian Network (RINET)
2020 – presente: Secretary, Immunotherapy Interest Group, European Academy of Allergy and Clinical Immunology (EAACI)
2020 – presente: Chair, Adult Asthma Committee, World Allergy Organization (WAO)
2019 – presente: Responsabile scientifico, Società Italiana di Allergologia e Immunologia Clinica (SIAAIC)
2018 – presente: Steering Committee Member, International Severe Asthma Registry (ISAR)
2018 – presente: Presidente, Accademia Italiana di Citologia Nasale (AICNA)
2017 – presente: Chair, Publication Committee, Severe Asthma Network in Italy (SANI)
2013 – 2019: Asthma Section Member, European Academy of Allergy and Clinical Immunology (EAACI)
2014 – 2019: Segretario, Società Italiana di Allergologia e Immunologia Clinica (SIAAIC)
2011 – 2013: Executive Committee Member, European Academy of Allergy and Clinical Immunology (EAACI)

Other / Note

Autore di oltre 200 articoli scientifici pubblicati su riviste internazionali peer-reviewed

Paoletti G, Racca F, Piona A, Melone G, Merigo M, Puggioni F, Ferri S, Azzolini E, Lagioia M, Lamacchia D, Cataldo G, Cecconi M, Canonica GW, Heffler E. Successful SARS-CoV-2 vaccine allergy risk-management: The experience of alarge Italian University Hospital. World Allergy Organ J. 2021 May;14(5):100541. doi: 10.1016/j.waojou.2021.100541. Epub 2021 Apr 8. PMID: 33850601; PMCID:PMC8030995.
Malipiero G, Paoletti G, Blasi F, Paggiaro P, Senna G, Latorre M, Caminati M, Carpagnano GE, Crimi N, Spanevello A, Aliberti S, Canonica GW, Heffler E. Clinical features associated with a doctor-diagnosis of bronchiectasis in theSevere Asthma Network in Italy (SANI) registry. Expert Rev Respir Med. 2021 Mar;15(3):419-424. doi: 10.1080/17476348.2021.1840983. Epub 2020 Nov 3. PMID:33100041.
Paoletti G, Melone G, Guida G, Pirola F, Malvezzi L, Pelaia C, Mariani A,Racca F, Malipiero G, Ferri S, Puggioni F, Spriano G, Canonica GW, Heffler E. Extended nitric oxide analysis in patients with chronic rhinosinusitis withnasal polyps, with or without associated asthma. J Breath Res. 2020 Nov 5;15(1):016007. doi: 10.1088/1752-7163/abc234. PMID: 33065563.
Heffler E, Detoraki A, Contoli M, Papi A, Paoletti G, Malipiero G, Brussino L, Crimi C, Morrone D, Padovani M, Guida G, Gerli AG, Centanni S, Senna G, Paggiaro P, Blasi F, Canonica GW; SANI Working Group. COVID-19 in Severe AsthmaNetwork in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments. Allergy. 2021 Mar;76(3):887-892. doi: 10.1111/all.14532. Epub 2020Aug 20. PMID: 32738147; PMCID: PMC7436509.
Canonica GW, Malvezzi L, Blasi F, Paggiaro P, Mantero M, Senna G, Heffler E; Severe Asthma Network Italy (SANI). Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy(SANI) registry. Respir Med. 2020 May;166:105947. doi:10.1016/j.rmed.2020.105947. Epub 2020 Apr 2. PMID: 32250875.

Enrico Marco Heffler

Hunimed

Risorse